» Articles » PMID: 33187055

High Prevalence of Gene Among Extended-Spectrum β-Lactamase-Producing Isolates Causing Extraintestinal Infections in Bangladesh

Overview
Specialty Pharmacology
Date 2020 Nov 14
PMID 33187055
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of multidrug-resistant (MDR) () clonal lineages with high virulence potential is alarming. Lack of sufficient data on molecular epidemiology of such pathogens from countries with high infection burden, such as Bangladesh, hinders management and infection control measures. In this study, we assessed the population structure, virulence potential and antimicrobial susceptibility of clinical isolates from Dhaka, Bangladesh. A high prevalence of MDR (69%) and extended-spectrum β-lactamase production (ESBL) (51%) was found. Most isolates were susceptible to amikacin (95%), meropenem (94%) and nitrofurantoin (89%) antibiotics. A high prevalence of ST131 (22%) and ST95 (9%) followed by ST69 (4%) and ST73 (3%) was observed. Phylogroups B2 (46%), B1 (16%), D (10%) and F (9%) were prominent. (52%) and (5%) were the most prevalent ESBL and carbapenem resistance genes, respectively. Moreover, the predominant pathotype identified was extraintestinal pathogenic (ExPEC) (41%) followed by enteric pathogens (11%). In conclusion, our results suggest the transmission of clonal groups amidst diverse population that are associated with high virulence potential and MDR phenotype. This is of high concern and mandates more efforts towards molecular surveillance of antimicrobial resistance (AMR) in clinically significant pathogens.

Citing Articles

A systematic review and meta-analysis on antibiotic resistance genes in Ghana.

Donkor E, Odoom A, Osman A, Darkwah S, Kotey F BMC Med Genomics. 2025; 18(1):47.

PMID: 40075357 PMC: 11899156. DOI: 10.1186/s12920-024-02050-y.


Genomic insights into plasmid mediated AMR genes, virulence factors and mobile genetic elements in raw milk Escherichia coli from Gujarat, India.

Mangroliya D, Adhyaru H, Kabariya J, Ramani V Sci Rep. 2025; 15(1):6320.

PMID: 39984597 PMC: 11845447. DOI: 10.1038/s41598-025-90761-2.


Prevalence and genomic insights of carbapenem resistant and ESBL producing Multidrug resistant Escherichia coli in urinary tract infections.

Sivarajan V, Ganesh A, Subramani P, Ganesapandi P, Sivanandan R, Prakash S Sci Rep. 2025; 15(1):2541.

PMID: 39833199 PMC: 11747333. DOI: 10.1038/s41598-024-84754-w.


Multidrug-Resistant Bacteria in Aquaculture Systems in Accra, Ghana.

Dayie N, Nathan-Mensah F, Kotey F, Kofi Adu Tabi B, Kabotso D, Odoom A Environ Health Insights. 2024; 18:11786302241299369.

PMID: 39600552 PMC: 11590155. DOI: 10.1177/11786302241299369.


Extended-spectrum β-lactamase-producing from poultry: A review.

Widodo A, Khairullah A, Effendi M, Moses I, Agustin A Vet World. 2024; 17(9):2017-2027.

PMID: 39507773 PMC: 11536724. DOI: 10.14202/vetworld.2024.2017-2027.


References
1.
Ahmed I, Rabbi M, Sultana S . Antibiotic resistance in Bangladesh: A systematic review. Int J Infect Dis. 2019; 80:54-61. DOI: 10.1016/j.ijid.2018.12.017. View

2.
Clermont O, Christenson J, Denamur E, Gordon D . The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013; 5(1):58-65. DOI: 10.1111/1758-2229.12019. View

3.
Hawkey P . Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect. 2007; 14 Suppl 1:159-65. DOI: 10.1111/j.1469-0691.2007.01855.x. View

4.
Ranjan A, Shaik S, Mondal A, Nandanwar N, Hussain A, Semmler T . Molecular Epidemiology and Genome Dynamics of New Delhi Metallo-β-Lactamase-Producing Extraintestinal Pathogenic Escherichia coli Strains from India. Antimicrob Agents Chemother. 2016; 60(11):6795-6805. PMC: 5075088. DOI: 10.1128/AAC.01345-16. View

5.
Suresh A, Ranjan A, Jadhav S, Hussain A, Shaik S, Alam M . Molecular Genetic and Functional Analysis of -Harboring, Extra-Intestinal Pathogenic From India. Front Microbiol. 2018; 9:2631. PMC: 6249908. DOI: 10.3389/fmicb.2018.02631. View